Luis Felipe Leite da Silva: Anti-EGFR Therapy in Metastatic Colorectal Cancer
Luis Felipe Leite da Silva, Medical Student at Fluminense Federal University, shared a post on LinkedIn about a paper he co-authored with colleagues published in Cancers:
“If you are interested in precision medicine and oncology, I invite you to read our recently published paper in Cancers.
Highlight:
‘This paradigm shift must be accompanied by careful consideration of cost-effectiveness, demonstrated survival benefit, and equitable access. As the field advances, integrating molecular complexity into routine practice must be balanced with the responsibility to ensure that innovations translate into meaningful improvements in patient outcomes.’
A special thanks to Thaís Megid for her inspiring mentorship and to our team of friends and Professors: Tiago Biachi de Castria, Renata D’Alpino Peixoto, Mariana Noronha, and Junior Samuel Alonso de Menezes!
Title: Anti-EGFR Therapy in Metastatic Colorectal Cancer: Identifying, Tracking, and Overcoming Resistance
Authors: Luís Felipe Leite, Mariana Macambira Noronha, Junior Samuel Alonso de Menezes, Lucas Diniz da Conceição, Luiz F. Costa Almeida, Anelise Poluboiarinov Cappellaro, Marcos Belotto, Tiago Biachi de Castria, Renata D’Alpino Peixoto, Thais Baccili Cury Megid
You can read the Full Article on Cancers.
More posts featuring Luis Felipe Leite da Silva.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023